New kidney drug PMG1016 enters first human safety trial
Disease control
Not yet recruiting
This early-stage study tests a new drug called PMG1016 in 30 healthy adults to see if it is safe and how the body processes it. The drug is given as a single IV infusion. This is the first time PMG1016 is being tested in humans, and it aims to gather safety data before moving to …
Phase: PHASE1 • Sponsor: Pulmongene Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC